To further validate these findings, we performed immunohistochemistry (IHC) on HCC samples, which demonstrated that GPR182 was barely detectable in the tumoral region compared to the peri-tumoral area (Fig. 1D). This evidence concerns the gene ACKR5 and hepatocellular carcinoma.